Breast Cancer Approach to Alzheimer’s Trial Design Could Improve Results, Scientists Contend

Breast Cancer Approach to Alzheimer’s Trial Design Could Improve Results, Scientists Contend
Research on Alzheimer’s treatments could benefit from the adaptive clinical trial approach used in breast cancer research, three Georgetown University scientists argue in a commentary. An adaptive approach involves modifying a trial as results come in to find the best way to treat the disease the trial is examining. The adaptive approach to breast cancer trials requires collaboration and data sharing among pharmaceutical firms, public research organizations, academic institutions, and patient advocacy groups, the Georgetown group noted in their viewpoint piece in the journal JAMA Neurology Scientists Mindi Messmer, Erin Wilhelm and Ira Shoulson acknowledged tha
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *